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What is Hepatocellular 
Carcinoma (HCC)?
HCC is the most common liver 
cancer
• It is the third most common cause 
of cancer-related death in the 
world and 7th in the United States
• Diagnosed late due to lack of 
symptoms until terminal stages
• Most often occurs in people with 
chronic liver disease
(Mayo, 2019, image)
(Mayo, 2019, para. 1)
(Ghouri, 2017, para. 1)
(Daher, 2018, pp. 69-78)
Etiology and Epidemiology
Majority of people with HCC already 
have Hepatitis B and C
• Hepatitis-B virus - most common in 
HCC patients 
• Hepatitis-C virus - second most 
common 
Alcohol-related Cirrhosis is also 
common among HCC patients 
• Nonalcoholic Fatty Liver Disease 
(NAFLD) is the third most 
common disease that occurs 
mainly in presence of cirrhosis, 
found to be a cause of HCC. 
HCC - most common among males 
ages 30-50
• Accounts for 65% of all liver 
cancers in U.S. (Ghouri, 2017, para. 3-10)
Treatment Options
Different treatment options include:
• Surgical resection 
• Liver transplantation 
• Limited due to lack of 
donors and strict 
indications
• Radiofrequency ablation therapy 
• Safety is dependent on 
where the tumor is located
• Chemotherapy 
• Radiation therapy 
• Due to the liver's 
sensitivity to radiation, this 
is limited and has not 
been thought of as an 
effective option
• Stereotactic Body 
Radiation Therapy, after 
recent studies, shows 
good local control rates 
for primary and metastatic 
liver cancers without risk 
of radiation-induced liver 
disease
• Targeted drug therapy
• Immunotherapy 
(Mayo, 2019, para. 4)
(Zhang, 2018, para. 1)
Stereotactic Body Radiation 
Therapy (SBRT)
Pros:
• Enables delivery of high dose 
radiation 
• Surrounding healthy tissue dose 
limited
• Shorter and less treatments make 
poor performance patients easier 
to treat
(Kato, 2015, pp. 13101-13112)
CyberKnife SBRT
• Ability to deliver precise treatments 
within one millimeter 
• More radiation is delivered to 
precise target area while 
preserving surrounding healthy 
tissue
• System combines intra-operative 
x-rays with previously acquired CT 
images of lesion to target each 
beam of radiation 
• Real-time tracking accounts for 
any movement and adjustments 
are made to ensure dose is 
delivered to treatment area
(Radiation Therapy News, 2014, image)
CyberKnife SBRT 
for HCC
(CyberKnife, 2017, p. 7)
(Stanford, 2020, para. 5)
CyberKnife (CK) is a good treatment 
option for patients ineligible for other 
main treatments.
It can be used for:
• pre-surgery therapy to down-stage 
a tumor
• Preventing tumor growth 
• Palliative therapy 
It makes radiation therapy treatment 
delivery extremely precise
• Limits exposure to healthy tissue
• Real-time tumor tracking makes 
any adjustments for motion 
In a study by Que et al., CK SBRT 
appeared to be a viable treatment 
option in patients with unresectable 
HCC
• Low risk of severe toxicity 
• 48.7% of patients had complete 
response 
• Overall survival at one and two 
years was 63.5% and 41.3%, 
respectively (Daher, 2018, pp. 69-78)(Que, 2016, pp. 1-10)
Conclusion
• HCC - most common liver cancer 
and one of the most common 
cancer-related deaths worldwide 
• CK offers near exact precision with 
treatment delivery using real-time 
tumor tracking
• Being precise, makes radiation 
therapy an effective & safe 
treatment for patients 
• Can be used palliatively, pre-
surgically, and to prevent any tumor 
growth
(Duttaradio, 2015, sl. 23)
(Que, 2016, pp. 1-10)
(Daher, 2018, pp. 69-78)
